Search results
Results from the WOW.Com Content Network
Additionally, NIAID partnerships with industry and academia have led to the advancement of diagnostic tests for several important infectious diseases, including malaria (ParaSight F), tuberculosis (GeneXpert MTB/RIF), and norovirus (Ridascreen Norovirus 3rd Generation EIA). NIAID has done research on mother-to-child transmission (MTCT) of HIV.
The ChemDB HIV, Opportunistic Infection and Tuberculosis Therapeutics Database is a publicly available tool developed by the National Institute of Allergy and Infectious Diseases to compile preclinical data on small molecules with potential therapeutic action against HIV/AIDS and related opportunistic infections. [1]
The Influenza Research Database (IRD) [1] [2] [3] is an integrative and comprehensive publicly available database and analysis resource to search, analyze, visualize, save and share data for influenza virus research.
Eli Lilly and Company (NYSE: LLY) said Monday that a trial of its antibody treatment for use in hospitalized COVID-19 patients has come to an end as the treatment is unlikely to help such patients.
In this episode of Yahoo Finance Presents Director of the National Institute of Allergy and Infectious Diseases, Dr. Anthony Fauci, talks to Yahoo Finance senior reporter Anjalee Khemlani about ...
The Vaccine Research Center (VRC), is an intramural division of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), US Department of Health and Human Services (HHS). The mission of the VRC is to discover and develop both vaccines and antibody-based products that target infectious ...
The Bioinformatics Resource Centers (BRCs) are a group of five Internet-based research centers established in 2004 and funded by NIAID (the National Institute of Allergy and Infectious Diseases.) [1] The BRCs were formed in response to the threats posed by emerging and re-emerging pathogens, particularly Centers for Disease Control and Prevention (CDC) Category A, B, and C pathogens, [2] and ...
For premium support please call: 800-290-4726 more ways to reach us